1) Myosin Light Chain Kinase
肌球蛋白轻链激酶
1.
Expression of myosin light chain kinase in acute lung injury;
肌球蛋白轻链激酶在急性肺损伤模型的表达及意义
2.
Rde of myosin light chain kinase in acute lung injury/acute respiratory distress syndrome;
肌球蛋白轻链激酶在急性肺损伤/急性呼吸窘迫综合征中的作用
3.
Effect of vitamin E on expression of myosin light chain kinase in the artery wall of atherosclerotic rabbits;
Vit E对动脉粥样硬化模型兔动脉肌球蛋白轻链激酶表达的影响
2) MLCK
肌球蛋白轻链激酶
1.
Objective:To evaluate the effect of endothelial MLCK and Rho/Rho kinase in extravascular m igration of tumor cell.
目的 :阐明肿瘤细胞向血管外游走过程中内皮细胞肌球蛋白轻链激酶 (MLCK)及Rho Rho激酶的调控作用。
2.
Objective To study the effect of insulin on the expression of myosin light chain kinase(MLCK) in the kindey of diabetic rats by constructing the experimental model of diabetic rats.
目的 复制实验性糖尿病大鼠模型,研究胰岛素对糖尿病大鼠肾脏肌球蛋白轻链激酶(myosin light chain kinase,MLCK)表达的影响,通过观察MLCK的动态变化,探讨肌球蛋白轻链激酶与糖尿病肾病发病机制的相关性。
3.
The objective of study was to compare the influences of wortmannin on platelet aggregation and platelet membrane surface glycoproteins GPIb expression after thrombin receptor activation,and to investigate the role of phosphatidylinositol 3-kinase (PI3-K) and myosin light chain kinase (MLCK) in the course of thrombin receptor activation.
本研究比较凝血酶受体活化过程中不同浓度的wortmannin对血小板聚集率以及血小板膜表面活化标记物糖蛋白GPIb表达的影响,探讨脂酰肌醇-3-激酶(PI3-K)与肌球蛋白轻链激酶(MLCK)在凝血酶信号传递机制中的作用。
3) Myosin light chain kinase (MLCK)
肌球蛋白轻链激酶
1.
It is generally accepted that the interaction between actin and phosphorylated myosin by myosin light chain kinase (MLCK) in a Ca2+-CaM dependent manner is the principal mechanism of regulation of smooth muscle contraction.
目前已公认的平滑肌收缩与舒张的主要调节机制是在Ca2+的参与下,由肌球蛋白轻链激酶(MLCK)催化的磷酸化肌球蛋白轻链(MLC20)与肌动蛋白的相互作用而产生收缩。
2.
Objective: Smooth muscle myosin light chain kinase (MLCK), which plays a regulatory role in the contraction of smooth muscle, phosphorylates 20kDa myosin light chain (MLC20) by an Ca2+/calmodulin(CaM) dependent manner and initiates smooth muscle contraction.
目的:平滑肌肌球蛋白轻链激酶(myosin light chain kianse, MLCK)作为调节平滑肌收缩的关键酶,可以通过与钙离子(Ca2+)/钙调蛋白(Calmodulin, CaM)的结合,使肌球蛋白20kD轻链磷酸化,进而激活肌球蛋白的ATP酶活性引起平滑肌收缩。
4) phosphorylated myosin light chain kinase
磷酸化肌球蛋白轻链激酶
1.
Objective To study the expression of phosphorylated myosin light chain kinase(P-MLCK) in human pulmonary arterial endothelial cell(HPAEC) induced by lipopolysaccharide(LPS).
目的探讨细菌脂多糖(LPS)对人肺动脉内皮细胞(HPAEC)表达磷酸化肌球蛋白轻链激酶(phosphorylated myosin lightchain kinase,P-MLCK)的诱导作用。
5) MLCK inhibitor ML-7
肌球蛋白轻链激酶抑制剂ML-7
6) myosin light chain kinase fragment (MLCKF)
肌球蛋白轻链激酶活性片段
补充资料：链激酶
分子式：暂无
分子量：暂无
CAS号：9002-01-1
性质：暂无
制备方法：暂无
用途：酶类药。
分子量：暂无
CAS号：9002-01-1
性质：暂无
制备方法：暂无
用途：酶类药。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条